Nyrada inc asx nyr


 Nyrada’s Lead Programs Advancing Well, Minimal Impact from COVID-19

Nyrada’s Lead Programs Advancing Well, Minimal Impact from COVID-19

June 26, 2020 02:42 PM AEST| By Team Kalkine Media

Australian listed pre-clinical stage drug discoverer and developer Nyrada Inc. (ASX: NYR) is initially focussing on the developing new treatments for cardiovascular and neurodegenerative diseases, specialising in novel small molecule drugs. Additio.....

AU_advertise

Advertise your brand on Kalkine Media

Recent Articles






Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.